ArticleDiscover oncology2026

CD300C reduces lung adenocarcinoma susceptibility through regulation of CD62L⁻ monocytes: a Mendelian randomization study.

Huiling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.